Association of Second Allogeneic Hematopoietic Cell Transplant vs Donor Lymphocyte Infusion With Overall Survival in Patients With Acute Myeloid Leukemia Relapse

JAMA Oncology - United States
doi 10.1001/jamaoncol.2018.2091
Full Text
Abstract

Available in full text

Date
Authors
Publisher

American Medical Association (AMA)

Related search

Second Allogeneic Hematopoietic Cell Transplantation Versus Donor Cellular Infusion for Relapse After Transplant

Biology of Blood and Marrow Transplantation
TransplantationHematology
2015English

No Association Between Donor Telomere Length and Outcomes After Allogeneic Unrelated Hematopoietic Cell Transplant in Patients With Acute Leukemia

Bone Marrow Transplantation
TransplantationHematology
2017English

Donor Lymphocyte Experience in Pediatric Allogeneic Hematopoietic Stem Cell Transplant Patients

Biology of Blood and Marrow Transplantation
TransplantationHematology
2018English

Sezary Syndrome in Relapse After Reduced Intensity Allogeneic Transplant Successfully Treated With Donor Lymphocyte Infusion

Bone Marrow Transplantation
TransplantationHematology
2008English

Extramedullary Relapse of Acute Myeloid Leukemia After Allogeneic Hematopoietic Stem Cell Transplantation

Biology of Blood and Marrow Transplantation
TransplantationHematology
2016English

Treatment of Relapsed Acute Myeloid Leukemia With MLL/AF6 Fusion After Allogeneic Hematopoietic Stem Cell Transplantation With Gemtuzumab Ozogamicin With a Long Interval Followed by Donor Lymphocyte Infusion

Leukemia
Cancer ResearchOncologyAnesthesiologyPain MedicineHematology
2007English

Donor Lymphocyte Infusion Induced Molecular Remission in Relapse of Acute Myeloid Leukaemia After Allogeneic Bone Marrow Transplantation

Bone Marrow Transplantation
TransplantationHematology
1999English

Prognosis of Patients With a Second Relapse of Acute Myeloid Leukemia

Leukemia
Cancer ResearchOncologyAnesthesiologyPain MedicineHematology
2000English

Increased Immune Suppression Is Associated With Worse Overall Survival in Allogeneic Hematopoietic Cell Transplant Patients Receiving Reduced Intensity Continuous Infusion Busulfan

Biology of Blood and Marrow Transplantation
TransplantationHematology
2017English

Amanote Research

Note-taking for researchers

Follow Amanote

© 2024 Amaplex Software S.P.R.L. All rights reserved.

Privacy PolicyRefund Policy